CBOA
CRL icon

Commonwealth Bank of Australia’s Charles River Laboratories CRL Stock Holding History

Commonwealth Bank of Australia’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-102,298
Closed -$6.17M – 845
2014
Q1 		$6.17M Buy
+102,298
New +$5.96M 0.04% 393

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Commonwealth Bank of Australia's CRL Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Charles River Laboratories (CRL) in Q2 2014, closing a stake of 102,298 shares — an estimated $6.17M sold.

Commonwealth Bank of Australia first reported a position in CRL in Q1 2014 and held it in 1 quarter. The position peaked at $6.17M in Q1 2014. 262 funds tracked by Wall St. Rank hold CRL as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining Charles River Laboratories position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 102,298 Charles River Laboratories shares in Q2 2014, an estimated $6.17M.
  • Commonwealth Bank of Australia first reported a position in Charles River Laboratories in Q1 2014 and held it in 1 quarter.
  • Commonwealth Bank of Australia's Charles River Laboratories position peaked at $6.17M in Q1 2014.
  • 262 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.